Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Biagetti

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Annali Italiani Di Chirurgia|February 8, 2014
Primary intra-abdominal synovial sarcoma: a case reportGrazia Travaglini, Simona Biagetti, Simona Alfonsi, et al.
Annali Italiani Di Chirurgia|February 22, 2014
Primary intra-abdominal synovial sarcoma: a case reportGrazia Travaglini, Simona Biagetti, Simona Alfonsi, et al.
Pathology, Research and Practice|December 1, 2010
Histological description of the lymphadenopathy related to Toscana virus infection. Report of a caseRenzo Ranaldi, Gaia Goteri, Simona Biagetti, et al.
Oncology Research|August 24, 2006
In vitro inhibition of promyelocytic leukemia/retinoic acid receptor-alpha (PML/RARalpha) expression and leukemogenic activity by DNA/LNA chimeric antisense oligosSara Caprodossi, Luca Galluzzi, Simona Biagetti, et al.
Future Oncology (London, England)|April 27, 2013
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximabMario Scartozzi, Riccardo Giampieri, Cristian Loretelli, et al.
Journal of Translational Medicine|April 12, 2012
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximabMario Scartozzi, Riccardo Giampieri, Elena Maccaroni, et al.
The Oncologist|January 8, 2011
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximabMario Scartozzi, Alessandra Mandolesi, Riccardo Giampieri, et al.
International Journal of Cancer|January 26, 2010
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecanMario Scartozzi, Alessandra Mandolesi, Riccardo Giampieri, et al.
European Journal of Haematology|May 18, 2013
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromesAntonella Poloni, Gaia Goteri, Antonio Zizzi, et al.
Analytical and Quantitative Cytology and Histology|August 12, 2010
Epidermal growth factor receptor gene promoter methylation in primary colorectal tumors and corresponding metastatic sites: a new perspective for an "old" therapeutic targetMario Scartozzi, Italo Bearzi, Alessandra Mandolesi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annali Italiani Di Chirurgia|February 8, 2014
Primary intra-abdominal synovial sarcoma: a case reportGrazia Travaglini, Simona Biagetti, Simona Alfonsi, et al.
Annali Italiani Di Chirurgia|February 22, 2014
Primary intra-abdominal synovial sarcoma: a case reportGrazia Travaglini, Simona Biagetti, Simona Alfonsi, et al.
Pathology, Research and Practice|December 1, 2010
Histological description of the lymphadenopathy related to Toscana virus infection. Report of a caseRenzo Ranaldi, Gaia Goteri, Simona Biagetti, et al.
Oncology Research|August 24, 2006
In vitro inhibition of promyelocytic leukemia/retinoic acid receptor-alpha (PML/RARalpha) expression and leukemogenic activity by DNA/LNA chimeric antisense oligosSara Caprodossi, Luca Galluzzi, Simona Biagetti, et al.
Future Oncology (London, England)|April 27, 2013
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximabMario Scartozzi, Riccardo Giampieri, Cristian Loretelli, et al.
Journal of Translational Medicine|April 12, 2012
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximabMario Scartozzi, Riccardo Giampieri, Elena Maccaroni, et al.
The Oncologist|January 8, 2011
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximabMario Scartozzi, Alessandra Mandolesi, Riccardo Giampieri, et al.
International Journal of Cancer|January 26, 2010
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecanMario Scartozzi, Alessandra Mandolesi, Riccardo Giampieri, et al.
European Journal of Haematology|May 18, 2013
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromesAntonella Poloni, Gaia Goteri, Antonio Zizzi, et al.
Analytical and Quantitative Cytology and Histology|August 12, 2010
Epidermal growth factor receptor gene promoter methylation in primary colorectal tumors and corresponding metastatic sites: a new perspective for an "old" therapeutic targetMario Scartozzi, Italo Bearzi, Alessandra Mandolesi, et al.
Pageof 1